This two-page fact sheet provides an overview of evidence and recommendations supporting the safety of the live attenuated CD-JEV Japanese encephalitis vaccine.
Corporate author(s): PATH
Publication date: February 2018
567 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Asia
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA